8-(1-piperazinyl)-2,3-dihydro-1,4-benzodioxin-6-carbonitrile | 161612-41-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 英文名称: 8-(1-piperazinyl)-2,3-dihydro-1,4-benzodioxin-6-carbonitrile
• 英文别名: 5-Piperazin-1-yl-2,3-dihydro-1,4-benzodioxine-7-carbonitrile
• CAS: 161612-41-5
• 化学式: C₁₃H₁₅N₃O₂
• 分子量: 245.281
• InChiKey: NEIKMVODDIXOHE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.8
• 重原子数：
  18
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.46
• 拓扑面积：
  57.5
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  8-(1-piperazinyl)-2,3-dihydro-1,4-benzodioxin-6-carbonitrile 、 二碳酸二叔丁酯 在 sodium hydroxide 作用下， 以 四氢呋喃 为溶剂， 反应 0.25h， 以0.1 g的产率得到1-(7-cyano-2,3-dihydro-benzo[1,4]dioxin-5-yl)-4-tert-butoxycarbonylpiperazin
  参考文献：
  名称：

  Synthesis of 7-Substituted-(2,3-dihydro-1,4-benzodioxin-5-yl)-piperazine

  摘要：

  A simple and versatile method for the synthesis of 7-substituted (2,3-dihydro-1,4-benzodioxin-5-yl)-piperazines starting from easy available class of derivatives has been developed.

  DOI：

  10.1080/00397910802219148
• 作为产物：
  描述：

  8-amino-2,3-dihydro-benzo[1,4]dioxine-6-carbonitrilebenzonitrile 、 二(2-氯乙基)胺盐酸盐 在 aluminum oxide 作用下， 反应 2.0h， 生成 8-(1-piperazinyl)-2,3-dihydro-1,4-benzodioxin-6-carbonitrile
  参考文献：
  名称：

  Synthesis of 7-Substituted-(2,3-dihydro-1,4-benzodioxin-5-yl)-piperazine

  摘要：

  A simple and versatile method for the synthesis of 7-substituted (2,3-dihydro-1,4-benzodioxin-5-yl)-piperazines starting from easy available class of derivatives has been developed.

  DOI：

  10.1080/00397910802219148

文献信息

• [EN] MULTIPLE D2 A(NTA)GONISTS/H3 ANTAGONISTS FOR TREATMENT OF CNS-RELATED DISORDERS<br/>[FR] MULTIPLES A(NTA)GONISTES DE D2/ANTAGONISTES DE H3 POUR LE TRAITEMENT DE TROUBLES ASSOCIÉS AU SNC
  申请人：AAPA B V

  公开号：WO2015069110A1

  公开（公告）日：2015-05-14

  The present invention relates to compounds compound according to Formula (III); and pharmaceutically acceptable salts, hydrates and solvates thereof. These compounds have D2receptor antagonist/(partial) agonist effects and H3antagonistic effects, pharmaceutical compositions thereof, and methods of using them for application in the prophylaxis or treatment of CNS disorders.

  本发明涉及按照式（III）的化合物；以及其药学上可接受的盐、水合物和溶剂合物。这些化合物具有D2受体拮抗/(部分)激动剂效应和H3拮抗效应，以及其药物组合物，以及将其用于预防或治疗中枢神经系统疾病的方法。
• [EN] BENZOXAZINONE DERIVATIVES, PREPARATION THEREOF AND USES IN THE TREATMENT OF CNS AND OTHER DISORDERS<br/>[FR] DERIVES DE BENZOXAZINONE, PREPARATION DE CEUX-CI ET UTILISATIONS DE CEUX-CI DANS LE TRAITEMENT DE TROUBLES DU SNC ET D'AUTRES TROUBLES
  申请人：GLAXO GROUP LTD

  公开号：WO2004046124A1

  公开（公告）日：2004-06-03

  Compounds of formula (I) and pharmaceutically acceptable salts thereof are disclosed:wherein A, R1, R2, R3, p, q, A and X are as defined in the specification. Preparation of the compounds and uses in the treatment of CNS and other disorders, including depression and anxiety, are also disclosed.

  公开了化合物的公式(I)及其药用盐：其中A、R1、R2、R3、p、q、A和X的定义如规范中所述。还公开了化合物的制备方法以及在治疗中枢神经系统和其他疾病，包括抑郁症和焦虑症中的用途。
• Benzoxazinone derivatives, preparation thereof and uses in the treatment of cns and other disorders
  申请人：Bertani Barbara

  公开号：US20060264429A1

  公开（公告）日：2006-11-23

  Compounds of formula (I) and pharmaceutically acceptable salts thereof are disclosed: wherein A, R1, R2, R3, p, q, A and X are as defined in the specification. Preparation of the compounds and uses in the treatment of CNS and other disorders, including depression and anxiety, are also disclosed.

  公开了化学式（I）的化合物及其药学上可接受的盐：其中A、R1、R2、R3、p、q、A和X的定义如规范中所述。还公开了这些化合物的制备方法以及在治疗中枢神经系统和其他疾病，包括抑郁和焦虑症方面的用途。
• BENZOXAZINONE DERIVATIVES, PREPARATION THEREOF AND USES IN THE TREATMENT OF CNS AND OTHER DISORDERS
  申请人：Bertani Barbara

  公开号：US20090076274A1

  公开（公告）日：2009-03-19

  Intermediates useful in the preparation of compounds of formula (I) and pharmaceutically acceptable salts thereof are disclosed: wherein A, R1, R2, R3, , p, q, and X are as defined in the specification.

  本文披露了在制备式(I)化合物及其药学上可接受的盐中有用的中间体：其中A、R1、R2、R3、p、q和X如规范中所定义。
• 2,3-Dihydro-1,4-benzodioxin-5-yl-piperazine derivatives having 5-HT1A-antagonistic activity
  申请人：DUPHAR INTERNATIONAL RESEARCH B.V

  公开号：EP0633260A1

  公开（公告）日：1995-01-11

  The present invention is concerned with compounds having 5-HT1A antagonistic activity useful in treating CNS disorders and having formula 2 wherein R₁ is halogen, lower alkyl or alkoxy, hydroxy, trifluotomethyl or cyano, m has the value 1 or 2 and n has the value 0 or 1, A represents an alkylene chain containing 2-6 C-atoms which may be substituted with one or more lower alkyl groups or a monocyclic (hetero)aryl group, and B is methylene, ethylene, carbonyl, sulfinyl, sulfonyl or sulfur, and salts thereof.

  本发明涉及的化合物具有 5-HT1A 拮抗活性，可用于治疗中枢神经系统疾病，具有式 2 其中 R₁ 是卤素、低级烷基或烷氧基、羟基、三氟甲基或氰基、 m 的值为 1 或 2，n 的值为 0 或 1、 A 代表含有 2-6 个 C 原子的亚烷基链，可被一个或多个低级烷基或单环（杂）芳基取代，以及 B 是亚甲基、亚乙基、羰基、亚砜基、磺酰基或硫、 及其盐类。